MedCity FemFwd: How Celmatix is Using ARPA-H’s Sprint for Women’s Health Funding

In this episode of MedCity FemFwd, Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, joins to discuss the $3.5 million funding awarded to Celmatix by ARPA-H through the Sprint for Women’s Health program. She talks about how Celmatix plans to use the funding to further their work in women’s health biotech. To learn more about this topic, you can listen to the full episode by clicking the link provided.

Source link